Clinical Trial

Lay User Evaluation of the Panbio™ HCV Self-Test

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 20, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, multi-centre study designed to evaluate the usability of the Panbio™ HCV Self Test, when performed by untrained lay users in an observed study setting. The Panbio™ HCV Self Test detects antibodies to Hepatitis C Virus (HCV). The study validation will be conducted in accordance with the World Health Organisation's technical guidance on Hepatitis C rapid diagnostic tests for professional use and/or self-testing (TSS-16).
Trial Details
NCT Number NCT06605573
Lead Sponsor Abbott Rapid Dx
Collaborators: Aga Khan University, Clinic 553 Karachi, Ezintsha Clinical Research Center
Conditions HEPATITIS C (HCV)
Enrollment 1,185 participants
Start Date 2024-10
Primary Completion 2025-03 (estimated)
Study Completion 2025-03 (estimated)
Updated on ClinicalTrials.gov 2024-09-20